Cognitive Assessment and Training in Healthcare Market

Executive Summary

Cognitive Assessment and Training in Healthcare Market was valued at US $5,544.76 million in 2021 and is projected to grow at 34.35% CAGR over the forecast period to reach US $32,602.04 million by 2027. Cognitive Assessment and Training in Healthcare Market represented US $2,472.71 million opportunity over 2019-2021 and estimated to create US $27,057.28 million opportunity in 2027 over 2021.

Cognitive Assessment and Training in Healthcare from Consainsights analyses the Cognitive Assessment and Training in Healthcare Market in the Life Sciences industry over the forecast period to 2027.

Cognitive Assessment and Training in Healthcare research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Cognitive Assessment and Training in Healthcare segmentation includes Component, Application and Geography.

Based on the Component, the Cognitive Assessment and Training in Healthcare analysis covers Solution, Services.

In Component segment, Solution segment has highest cagr growth of 30.01%.

Based on the Application, the Cognitive Assessment and Training in Healthcare analysis covers Clinical Trials, Screening And Diagnostics, Brain Training, Academic Research, Others.

In Application segment, Clinical Trials segment has highest cagr growth of 30.01%.

Based on the region, the Cognitive Assessment and Training in Healthcare analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include Cambridge Cognition Ltd., Bracket, Medavante Inc., Quest Diagnostics, Cogstate Ltd., Neurocog Trials, Prophase, Llc, Cognifit, Ert Clinical, Brain Resource Company and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

Component

Introduction

In 2021, Services segment has the highest revenue of US $3,210.90 million and is expected to grow at CAGR of 30.01% by 2027 Solution segment has highest cagr growth of 30.01%.

Solution

Solution segment was valued at US $1,293.07 million in 2019 and is projected to grow at 30.01% CAGR over the forecast period to reach US $13,722.62 million by 2027. Solution segment represented US $1,040.79 million opportunity over 2019-2021 and estimated to create US $11,388.76 million opportunity in 2027 over 2021.

Services

Services segment was valued at US $1,778.99 million in 2019 and is projected to grow at 30.01% CAGR over the forecast period to reach US $18,879.42 million by 2027. Services segment represented US $1,431.91 million opportunity over 2019-2021 and estimated to create US $15,668.53 million opportunity in 2027 over 2021.

Application

Introduction

In 2021, Clinical Trials segment has the highest revenue of US $2,480.37 million and is expected to grow at CAGR of 30.01% by 2027 Clinical Trials segment has highest cagr growth of 30.01%.

Clinical Trials

Clinical Trials segment was valued at US $1,374.24 million in 2019 and is projected to grow at 30.01% CAGR over the forecast period to reach US $14,584.08 million by 2027. Clinical Trials segment represented US $1,106.13 million opportunity over 2019-2021 and estimated to create US $12,103.71 million opportunity in 2027 over 2021.

Screening And Diagnostics

Screening And Diagnostics segment was valued at US $781.25 million in 2019 and is projected to grow at 30.01% CAGR over the forecast period to reach US $8,290.95 million by 2027. Screening And Diagnostics segment represented US $628.83 million opportunity over 2019-2021 and estimated to create US $6,880.88 million opportunity in 2027 over 2021.

Brain Training

Brain Training segment was valued at US $498.04 million in 2019 and is projected to grow at 30.01% CAGR over the forecast period to reach US $5,285.41 million by 2027. Brain Training segment represented US $400.87 million opportunity over 2019-2021 and estimated to create US $4,386.50 million opportunity in 2027 over 2021.

Academic Research

Academic Research segment was valued at US $241.05 million in 2019 and is projected to grow at 30.01% CAGR over the forecast period to reach US $2,558.11 million by 2027. Academic Research segment represented US $194.02 million opportunity over 2019-2021 and estimated to create US $2,123.04 million opportunity in 2027 over 2021.

Others

Others segment was valued at US $177.48 million in 2019 and is projected to grow at 30.01% CAGR over the forecast period to reach US $1,883.48 million by 2027. Others segment represented US $142.85 million opportunity over 2019-2021 and estimated to create US $1,563.15 million opportunity in 2027 over 2021.